Overall, CAR-T-EGFR cell infusion was correctly tolerated, except three patients with grade ≥3 acute fever/chills and several grade ≥3 events of lymphopenia and thrombocytopenia. The gene discussed is EGFR; the disease is Thrombocytopenia.